Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study

BACKGROUND: To ascertain if concurrent chemotherapy (CCT) benefits people with stage II nasopharyngeal carcinoma (NPC) treated with two‐dimensional radiotherapy (2DRT) or intensity‐modulated radiotherapy (IMRT). METHODS: A total of 4157 patients diagnosed with stage II NPC were evaluated. Patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Di‐Han, Zhou, Xiao‐Yu, Pan, You‐Guang, Chen, Si, Ye, Zheng‐Hao, Chen, Gang‐Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013074/
https://www.ncbi.nlm.nih.gov/pubmed/31859464
http://dx.doi.org/10.1002/cam4.2785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013074/
https://www.ncbi.nlm.nih.gov/pubmed/31859464
http://dx.doi.org/10.1002/cam4.2785

Ejemplares similares